Similar articles

• Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.

  Kenyon TA, Mwasekaga MJ, Huebner R, Rumisha D, Binkin N, Maganu E. Kenyon TA, et al. Int J Tuberc Lung Dis. 1999 Jan;3(1):4-11. Int J Tuberc Lung Dis. 1999. PMID: 10094163
• [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].

  Santos-Preciado JI, Franco-Paredes C. Santos-Preciado JI, et al. Rev Invest Clin. 2005 May-Jun;57(3):488-90. Rev Invest Clin. 2005. PMID: 16187710 Spanish. No abstract available.
• [Mycobacterium tuberculosis with extensive resistance].

  Labie D. Labie D. Med Sci (Paris). 2007 Feb;23(2):205-9. doi: 10.1051/medsci/2007232205. Med Sci (Paris). 2007. PMID: 17291432 Review. French. No abstract available.
• Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua.

  Chacón L, Lainez M, Rosales E, Mercado M, Caminero JA. Chacón L, et al. Int J Tuberc Lung Dis. 2009 Jan;13(1):62-7. Int J Tuberc Lung Dis. 2009. PMID: 19105880
• Extensively drug-resistant tuberculosis: new strains, new challenges.

  Banerjee R, Schecter GF, Flood J, Porco TC. Banerjee R, et al. Expert Rev Anti Infect Ther. 2008 Oct;6(5):713-24. doi: 10.1586/14787210.6.5.713. Expert Rev Anti Infect Ther. 2008. PMID: 18847407 Review.